Reason for request
Inscription
Mise à disposition de génériques des spécialités PROGRAF 0,5 mg, 1 mg et 5 mg, gélule
Clinical Benefit
| Substantial |
Le service médical rendu par les spécialités TACROLIMUS EG 0,5 mg, 1 mg et 5 mg est important dans les indications de l’AMM.
|
Clinical Added Value
| no clinical added value |
Absence d’amélioration du service médical rendu (ASMR V) par rapport à PROGRAF 0,5 mg, 1 mg et 5 mg, gélule.
|
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
KuXMH3hV2MGRE13P
